Vaxart Announces Publication in Vaccines of Non-Human Primate Preclinical Data Demonstrating Its Next-Generation Vaccine Candidates Elicit Mucosal and Systemic Immunogenicity and Reduce Viral Shedding after SARS-CoV-2 Challenge
— Data served as foundation for current vaccine candidate for planned Phase 2 research
— Vaxart vaccine candidates elicited strong antigen-specific serum IgG and IgA with neutralizing activity against multiple variants of concern
Related news for (VXRT)
- Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
- 24/7 Market News Snapshot 13 June, 2025 – Vaxart, Inc Common Stock (NASDAQ:VXRT)
- MoBot’s Stock Market Highlights – 06/13/25 03:00 PM
- Breaking News: MoBot’s Latest Update as of 06/13/25 01:00 PM
- MoBot’s Stock Market Highlights – 06/13/25 12:00 PM